UCB VENTURES
UCB Ventures is a €150 million strategic corporate venture fund
Similar Organizations
IBI Tech Fund
IBI Tech Fund is an Israeli fund investing in early-stage outstanding startups.
Current Employees Featured
Erica Whittaker Head of UCB Ventures @ UCB Ventures
Head of UCB Ventures
Delphine Hajaji Partner @ UCB Ventures
Partner
Alicia Iruzun Lafitte Partner @ UCB Ventures
Partner
Emmanuel Lacroix Partner @ UCB Ventures
Partner
Joshua Sands Principal @ UCB Ventures
Principal
Steven Biesmans Executive @ UCB Ventures
Executive
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-02-08 | Neurona Therapeutics | UCB Ventures investment in Series E - Neurona Therapeutics | 120 M USD |
| 2023-11-13 | ViaNautis | UCB Ventures investment in Series A - ViaNautis | 20 M GBP |
| 2023-03-14 | Switch Therapeutics | UCB Ventures investment in Series A - Switch Therapeutics | 52 M USD |
| 2022-06-07 | Code Biotherapeutics | UCB Ventures investment in Series A - Code Biotherapeutics | 75 M USD |
| 2022-02-15 | Splice Bio | UCB Ventures investment in Series A - Splice Bio | 50 M EUR |
| 2021-09-30 | EsoBiotec | UCB Ventures investment in Seed Round - EsoBiotec | 3 M EUR |
| 2021-06-22 | Neurona Therapeutics | UCB Ventures investment in Venture Round - Neurona Therapeutics | 41.5 M USD |
| 2021-04-20 | Rinri Therapeutics | UCB Ventures investment in Venture Round - Rinri Therapeutics | 10 M EUR |
| 2021-03-16 | StrideBio | UCB Ventures investment in Series B - StrideBio | 81.5 M USD |
| 2020-12-14 | Locanabio | UCB Ventures investment in Series B - Locanabio | 100 M USD |
More informations about "UCB Ventures"
Team - UCB Ventures
Reiner Class joined UCB Ventures in September 2024. Reiner started his journey at UCB in 2016 as Associate Director in Investigative Toxicology and transitioned to DMPK in 2023. Prior to joining UCB, Reiner spent 10 years at the largest …See details»
UCB
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions ... UCB Ventures invests in pioneering companies and technologies …See details»
UCB Ventures Org Chart + Executive Team - The Official Board
Organizational Chart of UCB Ventures. UCB Ventures Org Chart www.ucbventures.com. has 3 executives - and belongs to UCB +32 2559 9999; Add an executive. UCB Ventures (UCB) …See details»
Portfolio - UCB Ventures
Our Portfolio Direct Investments. We take an active role in our portfolio companies, contributing expertise in drug discovery, development and operations, to help them deliver maximum patient value.See details»
UCB Ventures - LinkedIn
UCB Ventures | 890 followers on LinkedIn. We are life science investors focusing on next-generation therapies. | UCB Ventures is the strategic corporate venture fund of UCB Pharma. Our mission is to further strengthen UCB's ability …See details»
UCB Ventures - Crunchbase Investor Profile
Find More Contacts for UCB Ventures. Protected Content. Associate. Non-Management Management 1 email found . View contacts for UCB Ventures to access new leads and connect with decision-makers. View All Contacts . …See details»
UCB Ventures - Power, Precision & Agility (Massachusetts / United ...
UCB Ventures is an evergreen strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can …See details»
UCB Ventures | UCB
Aug 10, 2020 ExeVir Bio: Collaborating and contributing to the fight against the global pandemic Read MoreSee details»
UCB Ventures - Investments, Portfolio & Company Exits
UCB Ventures 's most notable exits include EsoBiotec, MyHealthTeams, and Syndesi Therapeutics. Which industries has this organization had the most exits in? Show . EsoBiotec …See details»
UCB Ventures investment portfolio - PitchBook
UCB Ventures General Information Company Description. Founded in 2017, UBC Ventures is a venture arm of UCB based in Cambridge, Massachusetts. The firm seeks to invest in start-ups …See details»
UCB Ventures | UCB
UCB Ventures and AXA Venture Partners: seeking innovation in digital health Read MoreSee details»
Our News - UCB Ventures
Mar 13, 2025 UCB Ventures and AXA Venture Partners: seeking innovation in digital health. 18 Feb 2021. In this interview, UCB Ventures Partner, Delphine Hajaji, connects with François …See details»
UCB Ventures - Contacts, Employees, Board Members
UCB Ventures has 6 current employee profiles, including Head of UCB Ventures Erica Whittaker. Contacts. Edit Contacts Section. Job Department. Protected Content. Venture Capital …See details»
UCB Ventures Company Profile | Bruxelles, Belgium | Competitors ...
Find company research, competitor information, contact details & financial data for UCB Ventures of Bruxelles. Get the latest business insights from Dun & Bradstreet.See details»
UCB Ventures and AXA Venture Partners: seeking innovation in …
Feb 18, 2021 Delphine (D): Healthcare innovation has the potential to improve the lives of patients dramatically. And that is exactly why UCB Ventures has specifically been investing in …See details»
UCB Ventures - EU-Startups
UCB Ventures is a €150 million strategic corporate venture fund. UCB is a global biopharmaceutical company focused on neurology and immunology disorders, driven by …See details»
UCB Venture Fund: Performance - PitchBook
UCB Venture Fund is an early stage venture capital fund mangled by UCB Ventures. The fund is located in Cambridge, Cambridge. The fund targets pharmaceuticals and biotechnology, …See details»
UCB Ventures makes its first direct investment
Erica Whittaker, PhD, Vice President, Head of UCB Ventures, and Jayson Punwani, PhD, Partner, Takeda Ventures, Inc. have joined StrideBio’s Board of Directors. UCB Ventures is a strategic …See details»
On Growth Path for a Decade plus: Strong Launch Execution …
Feb 27, 2025 UCB Full-Year Report 2024, Brussels (Belgium), 27 February 2025 – 7:00 (CET) – regulated information . Jean-Christophe Tellier, CEO UCB says: “Our 2024 performance …See details»
To Make Better Decisions, Think Like a Venture Capitalist
2 days ago April 02, 2025. Venture capital firms notoriously embrace risk and take big swings, hoping that one startup will become a monster hit that pays for many other failed investments.See details»